Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Valéria Kecskeméti"'
Autor:
Bence Hegyi, Andrea Szebeni, Kornél Kistamás, János Magyar, Valéria Kecskeméti, Balázs Horváth, László Bárándi, Krisztina Váczi, Péter P. Nánási, Ferenc Ruzsnavszky, Norbert Szentandrássy, Tamás Bányász
Publikováno v:
European Journal of Pharmacology. 710:10-19
Despite its widespread therapeutical use there is little information on the cellular cardiac effects of the antidiabetic drug pioglitazone in larger mammals. In the present study, therefore, the concentration-dependent effects of pioglitazone on ion
Autor:
Valéria Kecskeméti, Tamás Bányász, Zsolt Bagi, Péter P. Nánási, János Magyar, Pal Pacher, Norbert Szentandrássy, László Fülöp
In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d909447c69bf6110807cd1fc5b5ed8ea
https://ora.ox.ac.uk/objects/uuid:42bf77f3-8d9d-4782-80b7-f8eaca1accf5
https://ora.ox.ac.uk/objects/uuid:42bf77f3-8d9d-4782-80b7-f8eaca1accf5
Autor:
Norbert Szentandrássy, Valéria Kecskeméti, József Simkó, Péter P. Nánási, Pal Pacher, Andrea Szebeni
Publikováno v:
Current Medicinal Chemistry. 18:3720-3728
Recent large clinical trials found an association between the antidiabetic drug rosiglitazone therapy and increased risk of cardiovascular adverse events. The aim of this report is to elucidate the cardiac electrophysiological properties of rosiglita
Autor:
Andrea Szebeni, Balázs Horváth, Norbert Szentandrássy, Gábor Harmati, József Simkó, László Bárándi, István Lőrincz, Péter P. Nánási, Valéria Kecskeméti, János Magyar, Tamás Bányász
Publikováno v:
British Journal of Pharmacology. 163:499-509
BACKGROUND AND PURPOSE In spite of its widespread clinical application, there is little information on the cellular cardiac effects of the antidiabetic drug rosiglitazone in larger experimental animals. In the present study therefore concentration-de
Autor:
Pal Pacher, Erzsébet Kocsis, Norbert Jost, Magdolna Tóth, András Varró, J. Gy. Papp, Péter P. Nánási, Valéria Kecskeméti, C Lengyel, Zs. M. Koltay, Peter Kovacs, László Virág, Attila Kristóf
Publikováno v:
Acta Physiologica. 192:359-368
Aim: In diabetes mellitus, several cardiac electrophysiological parameters are known to be affected. In rodent experimental diabetes models, changes in these parameters were reported, but only limited relevant information is available in other specie
Publikováno v:
Journal of Neurochemistry. 100:857-873
In recent years, there has been increasing evidence that serotonergic neurotransmission modulates a wide variety of experimentally induced seizures. Generally, agents that elevate extracellular serotonin (5-HT) levels, such as 5-hydroxytryptophan and
Autor:
P Pánczél, Valéria Kecskeméti, N Hosszúfalusi, Zoltán Prohászka, Katalin Uray, Guido Meierhoff, Ferenc Hudecz, György Füst, Nanette C. Schloot, Andrea Szebeni
Publikováno v:
Inflammation Research. 54:415-419
Rationale: Type 1 diabetes mellitus (T1) is considered to be an immune mediated disease. Based on previous findings it might be suggested that heat shock protein 60 (Hsp60) could be involved in the mediation of the development of the disease. Further
Autor:
Pal Pacher, Valéria Kecskeméti
Publikováno v:
Current Pharmaceutical Design. 10:2463-2475
The cardiovascular toxicity of older generation of tricyclic antidepressants (e.g. imipramine, desipramine, amitriptyline, clomipramine) and neuroleptics (e.g. haloperidol, droperidol, thioridazine, pimozide) is well established. These drugs inhibit
Publikováno v:
Scopus-Elsevier
A large number of oral antidiabetic agents are available today. This article provides a short review of the pharmacology and some clinical aspects of various oral antidiabetic drugs. It focuses mainly on the newest developing drugs (therapy of the ne